Spirogen Limited

Spirogen Limited is a biopharmaceutical company specializing in the development of targeted cancer therapies. The company utilizes its proprietary technology, PBD (pyrrolobenzodiazepine) dimer platform, to create novel drug conjugates that selectively target cancer cells while minimizing damage to healthy tissue. Spirogen's innovative approach has the potential to revolutionize cancer treatment by offering more effective and less toxic therapies. With a strong focus on research and development, Spirogen is committed to advancing its pipeline and bringing novel treatments to patients in need.